Markel Corporation
NYSE:MKLInsurance - Property & Casualty
-$18.15 today
- Market cap
- $23.73B
- Beta
- 0.67
- P/E (TTM)
- 11.7
- EPS (TTM)
- $157.85
Volume 0.04M
Average 0.07M
MKL Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Markel CorporationNYSE: MKL
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue remains negative
Q3 FY2026 cost of revenue was $0, compared with $1.98B a year earlier. Trailing-twelve-month cost of revenue was $4.57B. Over 3 fiscal years it compounded at -15.5% a year.
Context
- Cost of revenue amounted to 30.6% of revenue in FY2025, down 14.0 pp from a year earlier.
- Cost of revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly cost of revenue holds near $0 or moves back toward the trailing-twelve-month quarterly average of $1.14B.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 5.08B USD
- Year-over-year change
- -32.1%
- 4-year CAGR
- -7.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.08B | -32.1% |
| FY2024 | 2024-12-31 | 7.48B | -2.0% |
| FY2023 | 2023-12-31 | 7.63B | -9.2% |
| FY2022 | 2022-12-31 | 8.41B | +19.7% |
| FY2021 | 2021-12-31 | 7.03B | — |
Cost of Revenue vs competitors
How MKL compares with its peers on the latest reported figures
- MKL's LTM Sep 2026 cost of revenue of $4.57B is the 8th highest of the 11 companies compared; the peer median is $8.43B.
- Its year-over-year change of -34.7% is the 8th highest of 11, against a peer median of -16.7%.
- Cost of revenue amounts to 26.7% of revenue for MKL, versus a peer median of 51.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $35.58B | -14.8% | +9.5% | 57.3% | |
| LTM Sep 2026 | $31.87B | -8.1% | +6.7% | 65.1% | |
| LTM Sep 2026 | $12.48B | -27.6% | -8.4% | 43.0% | |
| LTM Jun 2026 | $10.33B | -18.5% | +22.8% | 53.8% | |
| LTM Sep 2026 | $10.01B | -0.5% | +7.8% | 66.4% | |
| LTM Sep 2026 | $6.85B | -40.8% | +10.5% | 38.1% | |
| LTM Jun 2026 | $6.04B | -12.8% | +6.2% | 74.0% | |
| LTM Sep 2026 | $4.57B | -34.7% | -15.5% | 26.7% | |
| LTM Sep 2026 | $956.57M | -6.8% | +17.3% | 49.0% | |
| LTM Sep 2026 | $890.88M | -35.9% | +11.0% | 45.9% | |
| LTM Sep 2026 | $869.95M | -80.1% | -8.3% | 16.3% | |
| Peer median (excluding MKL) | $8.43B | -16.7% | +8.6% | 51.4% | |
Competitors are the stored peer set for MKL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.92B | 11.81B | 15.71B | 16.75B | 16.59B |
| Cost of Revenue | 7.03B | 8.41B | 7.63B | 7.48B | 5.08B |
| Gross Profit | 5.89B | 3.41B | 8.08B | 9.27B | 11.51B |
| Gross Margin | 45.6% | 28.8% | 51.4% | 55.4% | 69.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 2.76B | 3.56B | 5.43B | 5.64B | 8.78B |
| Depreciation & Amortization | 336.39M | 309.45M | 319.73M | 342.36M | 347.92M |
| EBITDA | 3.65B | 353.94M | 3.16B | 4.18B | 3.29B |
| EBITDA Margin | 28.3% | 3.0% | 20.1% | 25.0% | 19.8% |
| Operating Income | 3.13B | (151.57M) | 2.65B | 3.64B | 2.73B |
| Operating Margin | 24.2% | -1.3% | 16.9% | 21.7% | 16.5% |
| Interest Income | 384.42M | 464.01M | 751.75M | 938.47M | 988.81M |
| Interest Expense | 183.58M | 196.06M | 185.08M | 204.3M | 205.91M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 3.13B | (151.57M) | 2.65B | 3.64B | 2.73B |
| Pre-Tax Margin | 24.2% | -1.3% | 16.9% | 21.7% | 16.5% |
| Income Tax Expense | 683.96M | (48.21M) | 552.62M | 790.29M | 580.3M |
| Net Income | 2.42B | (216.28M) | 2B | 2.75B | 2.11B |
| Net Margin | 18.8% | -1.8% | 12.7% | 16.4% | 12.7% |
| EPS (Basic) | 176.92 | (23.72) | 147.32 | 199.69 | 169.74 |
| EPS (Diluted) | 176.51 | (23.72) | 146.98 | 199.32 | 169.22 |
| Weighted Avg Shares | 13.77M | 13.58M | 13.35M | 13.02M | 12.7M |
| Weighted Avg Shares (Diluted) | 13.8M | 13.58M | 13.38M | 13.04M | 12.73M |
Markel Corporation
NYSE:MKL
Intrinsic Alpha fair value
Locked
Current Price
$1,940.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.